Zytiga and Intraocular pressure increased - a phase IV clinical study of FDA data

Summary:

Intraocular pressure increased is reported as a side effect among people who take Zytiga (abiraterone acetate), especially for people who are male, 60+ old, also take Xgeva, and have Prostate cancer.

The phase IV clinical study analyzes which people have Intraocular pressure increased when taking Zytiga. It is created by eHealthMe based on reports of 29,870 people who have side effects when taking Zytiga from the FDA, and is updated regularly.

What is Zytiga?

Zytiga has active ingredients of abiraterone acetate. It is often used in prostate cancer metastatic. eHealthMe is studying from 29,928 Zytiga users. Check the latest studies of Zytiga.

What is Intraocular pressure increased?

Intraocular pressure increased is found to be associated with 731 drugs and 951 conditions by eHealthMe. Check the latest studies of Intraocular pressure increased.

On May, 02, 2026

29,870 people reported to have side effects when taking Zytiga.
Among them, 15 people (0.05%) have Intraocular pressure increased.

Could Zytiga cause Intraocular pressure increased?

Among these 15 people:

What is the gender of people who have Intraocular pressure increased when taking Zytiga? *

female: 0.0 %
male: 100 %

What is the age of people who have Intraocular pressure increased when taking Zytiga? *

What are other drugs people take besides Zytiga? *

What are other side effects people have besides Intraocular pressure increased? *

Vision Blurred: 8 people, 53.33%
Prostatic Specific Antigen Increased: 8 people, 53.33%
Hyphaema (collection of blood inside the front part of the eye): 8 people, 53.33%
Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 8 people, 53.33%
Pigmentary Glaucoma (affliction of the eye that can lead to a form of glaucoma): 6 people, 40.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 6 people, 40.00%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 6 people, 40.00%
Cyclitis (inflammation of the ciliary body (eye)): 6 people, 40.00%
Malignant Neoplasm Progression (cancer tumour came back): 5 people, 33.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 33.33%

What are the existing conditions these people have? *

Prostate Cancer: 5 people, 33.33%
High Blood Pressure: 1 person, 6.67%
Bone Pain: 1 person, 6.67%
Bone Disorder: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zytiga and have Intraocular pressure increased?

- Check whether Intraocular pressure increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zytiga:

Zytiga (29,928 reports)

Browse all side effects of Zytiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intraocular pressure increased:

Intraocular pressure increased (731 drugs)

Browse all the conditions that are associated with Intraocular pressure increased:

Intraocular pressure increased (951 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abiraterone acetate (the active ingredients of Zytiga) and Zytiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.